Lucas Franki is an associate editor for MDedge News, and has been with the company since 2014. He has a BA in English from Penn State University and is an Eagle Scout.
News
Social anxiety more likely with inattentive ADHD, psychiatric comorbidities
Learning and communication disorders, and anxiety disorders were the most common among patients.
News
First generics for Gilenya approved by FDA
Approvals for fingolimod generics were issued to three companies.
News
Benefits and drawbacks found for risk-based lung cancer screening tools
Modeling indicated risk-based lung cancer screening tools could prevent significantly more lung cancer deaths, but life-year gains were negligible...
News
Prosody recognition associated with functioning in first-episode schizophrenia
"These findings are consistent with the view that emotion recognition deficits could be contributing to deficits in the ability of people with...
News
Childproofing your protocols, and what’s the deal with airline water?
Plus, why Carl Spackler’s chrysanthemum-based golf drills won’t improve your short game.
News
High recurrence, shortening cycle length in bipolar disorder associated with several biomarkers
“These results suggest the potential for translational research aimed at preventive actions,” the investigators wrote.
News
FDA approves Oxbryta for sickle cell disease treatment
The drug, which is approved for adults and children aged 12 years and older, improved hemoglobin in the HOPE trial.
News
Alkermes submits NDA for new schizophrenia, bipolar I treatment
Data from the ENLIGHTEN-1 and ENLIGHTEN-2 studies are included in the application for ALKS 3831, a combination of olanzapine and samidorphan.
News
FDA: Two repackagers issue voluntary ranitidine recall
More companies have issued voluntary recalls of their repackaged ranitidine products because of possibly unacceptable levels of N-...
News
FDA approves acalabrutinib for CLL, SLL treatment
The approval was made as part of Project Orbis, a collaboration among the FDA, the Australian Therapeutic Goods Administration, and Health Canada...
News
FDA approves Givlaari for treatment of acute hepatic porphyria
Prior to this approval, existing treatments provided only partial relief from porphyria attacks, according to the FDA.
News
Grading Dr. Google and treating malaria by the bowlful
Plus, serious water conservation faces a “roadblock of disgust.”
News
FDA announces approval of fifth adalimumab biosimilar, Abrilada
Pfizer said that current plans are to launch the drug in the United States in 2023.
News
FDA approves Pentax duodenoscope with sterile, disposable elevator
Disposable designs reduce or eliminate the need for reprocessing certain components, a major source of between-patient duodenoscope contamination...
News
FDA approves Brukinsa for relapsed, refractory MCL
The Bruton tyrosine kinase (BTK) inhibitor zanubrutinib showed high overall response rates in two clinical trials.